Skip to content

Author

Yue Zhou

We have 3 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Synthesis, anti-Xanthomonas oryzae pv. oryzae activity and antibacterial mechanism of indole-3-substituted-1,3,4-oxadiazole derivative.

BACKGROUND Bacterial leaf blight (BLB) caused by Xanthomonas oryzae pv. oryzae (Xoo) seriously endangers global rice production. It is urgent to explore efficient and low-toxic antibacterial candidates for sustainable bacterial blight management. RESULTS Herein, 25 indole-3-substituted 1,3,4-oxadiazole derivatives we...

Meng-Zhi Yang, Xiao-Hua Wang, Yue Zhou et al. · 0 citations
Jul 2026

Design, Synthesis, and Mechanistic Investigation of Novel 1,3,4-Thiadiazole Derivatives Bearing a Morpholine Moiety Against Xanthomonas oryzae pv Oryzae.

Mechanical studies revealed H6 inhibits biofilm and extracellular polysaccharide formation, disrupts membrane integrity, induces ROS accumulation, and promotes lipid peroxidation, underscoring H6 as a promising bactericidal agent, demonstrating considerable potential in sustainable management of plant bacterial disease...

Mengzhi Yang, Cheng-Peng Li, Yue Zhou et al. · 0 citations
Aug 2026

Novel Piperlongumine derivatives exert multimodal antitumor effects in prostate cancer via MAPK pathway activation, poly-mechanistic apoptosis induction, and DNMT3A-mediated DNA methylation reduction.

In vivo validation in PC-3 xenograft mice confirmed that 11 M exerted robust tumor growth suppression with low systemic toxicity, accompanied by DNMT3A downregulation and MAPK pathway activation, substantiating its multi-target therapeutic mechanism.

Yu Zhang, Xue Yang, Xuemei Qiu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.